Brad Nelson Dr. Ulla Grauschopf
|
|
- Clemence Fox
- 6 years ago
- Views:
Transcription
1 Plenary Session Brad Nelson is the Professor of Robotics and Intelligent Systems at ETH Zürich. His primary research focus is on microrobotics and nanorobotics emphasizing applications in biology and medicine. He received a B.S.M.E. from the University of Illinois and an M.S.M.E. from the University of Minnesota. He has been at Honeywell and Motorola and served as a United States Peace Corps Volunteer in Botswana, Africa, before obtaining a Ph.D. in Robotics from Carnegie Mellon University in He was Assistant Professor at the University of Illinois at Chicago ( ) and Associate Professor at the University of Minnesota ( ). He became Full Professor at ETH Zürich in He has received a number of awards and serves on several editorial boards. He has been Department Head of Mechanical and Process Engineering, Chairman of the ETH Electron Microscopy Center, and a member of the Research Council of the Swiss National Science Foundation. Dr. Ulla Grauschopf was appointed Head of Device Development at Hoffmann-La Roche in Basel mid of She is a biochemist by training with a strong focus on biophysical characterization of protein molecules and joined Roche after some years in academic research. Ulla's background spans more than 11 years of technical R&D experience in all fields of drug product development, including formulation, analytics, drug product process, manufacturing & transfer, primary packaging and device, and regulatory strategies.
2 Plenary session Dr. Bassil Akra is the vice president of the global focus teams (Cardiovascular, Orthopedic and Clinical) at TÜV SÜD Product Service. Dr. Akra has long experience in research, development, quality management and regulatory approval of medical devices, combination devices and ATMP products. Dr. Akra is leading various consultation processes of medical devices incorporating an ancillary medicinal sub- stance with the different competent authorities designated by the Member States or the EMA. As a senior field expert, he is presenting worldwide the requirements in Europe and is involved in the development of several European guidance documents and standards. He is member of the European Clinical Investigation and Evaluation working group and is representing Team NB and NB MED in several European discussions regarding the clinical requirements such as MEDDEV and other Guidance Documents on Innovative Devices. Dr. Akra is member of the German MDR Implementation Working Group, the NAKI. He is also member of the European task force on Safety Update Reporting.
3 Workshop 1 Priscilla Brunetto was born in New Caledonia. She obtained her Bachelor and Master degree in Biochemistry from the University Claude Bernard Lyon 1, France in 2004 and received her Ph.D. degree in Chemistry from the University of Fribourg, Switzerland in 2010 under the direction of Professor Dr. Katharina M. Fromm. Her Ph.D. research was focused on the development of new antimicrobial surfaces for implants and medical devices application. From 2010 to 2015, she continued her work on antimicrobial surfaces as project leader for CTI projects at the University of Fribourg, Switzerland. Since 2015, she works as a Maître- Assistante at the University of Fribourg, Switzerland in the group of Prof. Dr. Katharina M. Fromm Vanya Loroch is a life science educator, writer and advisor with a broad expert knowledge in biology, biotechnology, medical information management, health promotion and prevention, sports doping and anti-doping. Leveraging on his twenty year experience in innovative educational projects, Dr. Loroch has developed a highly effective method for introductory and continuing education aimed at all professionals, that need to gain a sound understanding of life sciences. He is the Education Director of the SBA Academy and Professor at the Lausanne Business School where he teaches Biology for Sustainable Business, a unique course that links life sciences to sustainability for the benefit of future business leaders.
4 Workshop 2 Christa Spitznagel studierte Pharmazie an der ETH in Zürich. Sie verfügt über langjährige Pharma- Industrieerfahrung mit Kernkompetenzen im Bereich Regulatory Affairs, Health Care Compliance, Pharmacovigilance und Medical Information. Für Allergan arbeitete sie seit 6 Jahren als Leiterin der Regulatory Affairs Abteilung, zuständig für die Schweiz und Österreich. Auf Grund des breiten Portfolios an Arzneimitteln und verschiedener Kategorien von Medizinprodukten der Klassen II und III kennt sie sich mit klinischen Daten und deren Aufarbeitung und Erstellung zur Erlangung der Zulassung sehr gut aus. Sie ist Mitglied verschiedener beruflicher Gremien: Vorstandsmitglied der MEGRA und Leitung der MEGRA-Fachgruppe Pharmacovigilance; Mitglied der Arbeitsgruppe Datenpolitik von Scienceindustries. Ivo Schauwecker holds a degree in biochemistry and a diploma in Pharmaceutical Medicine (EUCOR/ECPM). He has over 20 years of operational experience in international clinical research in the pharmaceutical, medical device and CRO industry. He started his career in clinical research with the CRO Pharma Focus Consultants (now Clinipace) in Switzerland. After that he became co-founder of the CRO Appletree in Switzerland and was serving the company for 6 years. He joined the clinical research institute AOCID of the AO Foundation 7 years ago. At the AOCID he is member of the managing team and is responsible for various fields of activities. His responsibilities are client relations and business development as well as vendor management. He is supporting the development of the educational activities and acts as faculty in various international courses offered by AOCID. He also serves as board member of the Swiss Association of Pharmaceutical Professionals (SwAPP) for more than 14 years.
5 Workshop 3 Kathrin Abegg studied Veterinary Medicine with a focus on Biomedical Research at the University Zürich. She completed a PhD thesis in the field of obesity and diabetes research and a postdoc for the evaluation of a potential novel treatment option for diabetes mellitus. The results of both research projects were published in the peer-reviewed literature. After leaving academic research, she was involved in the approval of animal experiments at the Veterinary Office of the Canton of Zürich for a year before starting as Clinical and Regulatory Affairs Manager with ISS AG in Her focus at ISS AG lies with the preparation of clinical evaluation reports and with the implementation of changes brought about by the new EU Medical Devices Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) with regard to clinical evaluations and performance evaluations of IVDs. Rainer Voelksen started his career in regulatory affairs (RA) with a French veterinarian pharma company then with two major osteosynthesis/joint prosthesis manufacturers in Switzerland. For two years Rainer was the director of RA Europe for US biotech company Genzyme, the Netherlands. In 1998, he joined the Swiss Government regulator for medical devices (MD), which became Swissmedic later on. In 2005, he joined the Australian Therapeutic Goods Administration (TGA) for a one-year delegation from Swissmedic. After that year, he built up the Asia Pacific regulatory network for Synthes, being based in Australia. Back in Europe, he joined GE Healthcare in Paris as the executive for regulatory and quality affairs, later Edwards Lifesciences as VP of international RA. After some years at Swiss Federal Office of Public Health to implement the new EU MD and IVD regulations into Swiss law, followed by two years at a Swiss cardio-vascular group (as VP RA & QM). Recently Rainer moved to become a Senior RA strategy consultant. Being a member of RAPS for more than 20 years, Rainer served as chairman of RAPS board of directors. He was awarded the RAPS Fellow distinction in September of He serves as the cochair of the European advisory committee of RAPS.
Other appointments: Chairman of the Advisory Committee of Zentiva Group, Industrial Advisor EQT.
Executive Committee Guido Oelkers Chief Executive Officer Born 1965. Employed since 2017. PhD in Strategic Management, University of South Australia, Master of Economics, South Bank University, London,
More informationLife Sciences Queensland announces latest LSQ Ambassadors
MEDIA RELEASE Monday 22 April, 2013 FOR IMMEDIATE RELEASE Life Sciences Queensland announces latest LSQ Ambassadors (LSQ) is pleased to announce our latest LSQ Ambassadors - two of the life sciences industry
More informationMENTORS REGULATORY AFFAIRS. Christophe AMIEL Head of Medical Device & Digital, Voisin Consulting Life Sciences STRATEGY/BUSINESS
Hosted by : INNOLABS IDEAS CONTEST 21 st -22 nd June, Paris MENTORS REGULATORY AFFAIRS Christophe Amiel is heading the design and operational implementation of international regulatory strategies as Senior
More informationExclusive. InterContinental Shanghai, Expo Pudong New District, Shanghai Thursday October 27, 2016
InterContinental Shanghai, Expo Pudong New District, Shanghai Thursday October 27, 2016 Exclusive Asia Cicor Innovation Insights Symposium Opportunities and Challenges for Medical Devices companies Asia
More informationInternational Conference on Pharmaceutical Research and Development June 06-07, 2018 Philadelphia, USA
International Conference on Pharmaceutical Research and Development,, https://research.pharmaceuticalconferences.com Invitation Dear Attendees, We are glad to announce the International Conference on Pharmaceutical
More informationMagalie Wasem Tréguer. Executive Summary. Säntisstrasse 93, 8820 Wädenswil, Switzerland +41 (0) / +41 (0)
Magalie Wasem Tréguer Säntisstrasse 93, 8820 Wädenswil, Switzerland +41 (0)79 290 47 46 / +41 (0)43 343 94 91 mwasem@pharmalawsolutions.com Executive Summary International legal counsel trained at a leading
More informationIgor Fisch. New candidate, independent
Igor Fisch New candidate, independent Igor Fisch is a co-founder of Selexis SA, a biotech company based in Switzerland. He grew the company from inception to profits in less than 5 years with up to > 5MCHF
More informationANNUAL GENERAL MEETING OF SHAREHOLDERS AFFIMED N.V.
ANNUAL GENERAL MEETING OF SHAREHOLDERS AFFIMED N.V. to be held on Tuesday, June 19, 2018 at 15:00 hrs. (CET) at Amsterdam Marriott Hotel, Stadhouderskade 12, 1054 ES Amsterdam, the Netherlands Agenda 1
More informationthe SPD company Dr Clive Simon, Principal, The SPD Company.
the SPD company With decades of local and international experience at the coalface, The SPD Company s specialists have built a solid repertoire of in-depth technical knowledge within the highly-regulated
More informationBiotech Concerto #6 Investment Process December 2008
Biotech Concerto #6 Investment Process December 2008 Index Biotech Investment Characteristics Investment Policy Investment Team Scientific Advisory Board Deal Flow Attrition Rate From Screening to Decision
More informationDiagnostic assays based on molecular markers Discussion platform on patenting procedures - exchange with NPOs
Diagnostic assays based on molecular markers Discussion platform on patenting procedures - exchange with NPOs Programme Draft 10 11 May 2016 Warsaw, Poland In co-operation with: Venue Patent Office of
More informationBorn Ph.D. from Karolinska Institutet in Stockholm. Board member since 2016.
Board of Directors Håkan Björklund Chairman Born 1956. Ph.D. from Karolinska Institutet in Stockholm. Board member since 2016. Other appointments: Currently serves as Industry Executive at Avista Capital
More informationClinical Forum Attendee Sample Job Titles
Account Executive Account Manager Account Manager, New Sales Development - Europe Advisor, Global Medical Channels and ecapabilities Area Sales Director Assistant Director.Assistant Director Pharm. Tr.
More informationIntegrated Scientific Advice Workshop: ISPOR Glasgow
Integrated Scientific Advice Workshop: ISPOR Glasgow Early Integrated Scientific Advice in Product Development: Get Real and Adapt to Accelerate Patient Access ICONplc.com Overview At today s patient-centered
More informationGlobal Pharmaceuticals
ROSENFIELD PR OGR AM in public affairs, international relations, and human rights Global Pharmaceuticals February 3 5, 2009 GRINNELL COLLEGE Global Pharmaceutical Symposium February 3-5, 2009 Tuesday,
More informationSeptember 27, 2016, Priora Business Center, Kloten Zurich Airport / Switzerland
September 27, 2016, Priora Business Center, Kloten Zurich Airport / Switzerland Opportunities and Challenges for Medical Devices companies expanding to Asia Third Cicor Innovation Insights Symposium Supported
More informationYour Content Your Way
MY VIEW Your Content Your Way My View allows you to view only the topics you want to follow. Choose from a list of available topics, which are individualized for each publications, and design your own
More informationOracle Suite Update Update of the Argus Suite Release Roadmap Speaker: Industry, Oracle
Wednesday October 18 6:00 9:00pm Cocktail Reception Kick off AUG Boston by mingling with your peers while enjoying cocktails and an array of appetizers. Apropos Restaurant, lobby level, Boston Sheraton
More informationINDIAN SOCIETY FOR CLINICAL RESEARCH
INDIAN SOCIETY FOR CLINICAL RESEARCH 12 th Annual Conference Clinical Research Advancing the Frontiers of Health February 15-16, 2019, New Delhi Pre-Conference Workshops February 14, 2019 Track III Biostatistics
More informationJURY BOARD BUSINESS/INVESTMENT. Pascal BECACHE Founding President, PBS, Healthcare Industry STRATEGY/BUSINESS
Hosted by : Pascal BECACHE Founding President, PBS, Healthcare Industry INNOLABS IDEAS CONTEST 21 st -22 nd June, Paris JURY BOARD BUSINESS/INVESTMENT Pascal is a seasoned executive with GM and Sales VP
More informationRoche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo Dr. Axel Braun F. Hoffmann La Roche Ltd.
Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo 2011 Dr. Axel Braun F. Hoffmann La Roche Ltd. Content Roche Company Profile The IP Department Patent Filings Global Strategy Sales Overview IP
More informationABRAHAM ABUCHOWSKI, PH.D.
ABRAHAM ABUCHOWSKI, PH.D. Biographical Sketch Dr. Abuchowski is the developer of the current gold standard technology for protein drug delivery called PEGylation. The development of this technology was
More informationEUROPE March Brussels, Belgium CALL FOR ABSTRACTS. Join Us at the Crossroads of Healthcare. DIAglobal.org/Europe2020 #DIAEurope2020
EUROPE 2020 17-19 March Brussels, Belgium CALL FOR ABSTRACTS Join Us at the Crossroads of Healthcare I1 Steering Committee Francis Arickx INAMI, Belgium Matthieu Boudes EPF, Belgium Sini Eskola EFPIA,
More informationBREAKTHROUGH CONVENTION SUMMARY JUNE SAN DIEGO CONVENTION.BIO.ORG #BIO2017
BREAKTHROUGH CONVENTION SUMMARY JUNE 19-22 SAN DIEGO CONVENTION.BIO.ORG #BIO BIO BY THE NUMBERS FEATURING SEVERAL THEMATIC EXHIBITS 16,123 ATTENDEES 74 48 COUNTRIES STATES 18,000 MORE THAN EXHIBITORS 41,400
More informationOmeros Raises More Than $63 Million in Financing
Omeros Raises More Than $63 Million in Financing Seattle, WA February 12, 2007 Omeros today announced that it has raised in excess of $63 million in an oversubscribed Series E equity financing. New investors,
More informationOverview of speakers Biocides Stakeholders Day. 1 September 2015 Helsinki, Finland
Overview of speakers Biocides Stakeholders Day 1 September 2015 Helsinki, Finland Plenary session 1 Opening Geert Dancet became the first elected Executive Director of the European Chemicals Agency (ECHA)
More informationTo the shareholders of Nordic Nanovector ASA Oslo, 8 May 2018
To the shareholders of Nordic Nanovector ASA Oslo, 8 May 2018 RECOMMENDATION OF THE NOMINATION COMMITTEE 1. INTRODUCTION The Nomination Committee of Nordic Nanovector ASA comprises of Johan Christenson
More informationMedical Device Innovation Forum
Medical Device Innovation Forum 08:30-12:00, August 28 Co-Chair: Xu Wei Director of Center for Medical Device Evaluation, CFDA, Deputy Chief Physician, Master of Medicine. She once served as the Head of
More informationMolecular Pathology. Theme: Exploring the clinical practices and research ideas in the field of molecular Pathology. Molecular Pathology 2019
International Conference on Molecular Pathology July 31-August 01, 2019 Amesterdam, Nertherlands Theme: Exploring the clinical practices and research ideas in the field of molecular Pathology Invitation
More informationData-Driven Evaluation: The Key to Developing Successful Pharma Partnerships
R&D Solutions for PHARMA & LIFE SCIENCES DRUG DISCOVERY & DEVELOPMENT Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships Summary For pharmaceutical companies to succeed, it is
More informationDr. Eberhard Bessey. Daimler AG Group Research and Advanced Engineering (GR&AE)
Dr. Eberhard Bessey Daimler AG Group Research and Advanced Engineering (GR&AE) Group Research Product Innovations and Process Technologies - Materials Manufacturing Concepts (GR/PM) Senior Manager Technology
More informationInternational Strategy Development Training: a personal strategic development workshop for Life Sciences Executives of SMEs
International Strategy Development Training: a personal strategic development workshop for Life Sciences Executives of SMEs Do you want to strengthen your business plan for your company?, or refresh your
More informationJan Cobbenhagen. E: W:
Jan Cobbenhagen Jan Cobbenhagen (1963) is active in the business and academic communities. He holds both CEO and supervisory positions. His current responsibilities are: CEO of Maastricht University Holding
More informationThe Assessment of Benefits and Harms and Their Relative Importance for Patients, Industry and Agencies: How should they be captured?
The Assessment of Benefits and Harms and Their Relative Importance for Patients, Industry and Agencies: How should they be captured? 2-3 April 2014 PROGRAMME Woodlands Park Hotel, Cobham, Surrey, UK CENTRE
More informationNUS Institute of Systems Science appoints Janet Ang as new Chairperson
PRESS RELEASE 31 MARCH 2016 FOR IMMEDIATE RELEASE NUS Institute of Systems Science appoints Janet Ang as new Chairperson Tech veteran succeeds Institute s longest serving Chairman Professor Christopher
More informationPierre Jaccoud. Personal Data. Pierre Jaccoud March 4, 1955 Married; two daughters Swiss, citizen of Basel and Puidoux (VD)
Personal Data Pierre Jaccoud March 4, 1955 Married; two daughters Swiss, citizen of Basel and Puidoux (VD) Education Schools in Basel and Grisons (Samedan and Schiers) Law studies at the university of
More informationPrivate Equity and Venture Capital in Switzerland
Private Equity and Venture Capital in Switzerland Venture Valuation VV AG Badenerstr. 18 8004 Zurich Switzerland Phone +41 (43) 321 86 60 Fax + 41 (43) 321 86 61 info@venturevaluation.ch Agenda - Overview
More informationMedical Device Clinical Trial Forum
Medical Device Clinical Trial Forum 08:30-12:00, August 28 Co-Chair: Feng Xiaoming Research Fellow of China Food and Drug Testing Institute, Deputy Director of Biomaterial and Tissue Engineering Lab, working
More informationWelcome. There s no more exciting time, and no more exciting place, to put your talents to work.
Welcome There s no more exciting time, and no more exciting place, to put your talents to work. My life before McKinsey Born in Lausanne Exchange at the University of Birmingham PhD in Group Theory at
More informationLehigh University Team biographies. October 30, 2017
Lehigh University Team biographies October 30, 2017 Core team members 2 Lane McBride Partner and Managing Director, Washington, DC Lane McBride is a Partner and Managing Director in the Washington, D.C.
More informationA Brief Introduction to the Regulatory Environment of Medical Device Supervision. CFDA Department of Legal Affairs Liu Pei
A Brief Introduction to the Regulatory Environment of Medical Device Supervision CFDA Department of Legal Affairs Liu Pei Development Trend of Medical Device Industry Development Opportunities of Medical
More informationArticle 117 A Notified Body perspective, advice on how and when to engage notified bodies
TOPRA Annual Medical Devices Symposium 2017 Article 117 A Notified Body perspective, advice on how and when to engage notified bodies Theresa Jeary, Head of Notified Body Medical Devices, LRQA ENABLING
More informationAnnual Benefit-Risk Workshop
Annual Benefit-Risk Workshop Implementing an Internationally Acceptable Framework for the Benefit- Risk Assessment of Medicines: How close are we to this objective? 20-21 June 2013 PROGRAMME Venue: The
More informationWhere the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes
Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes Scientific innovation is at the heart of everything we do. Scientific innovation is at the heart of our business and
More informationIntellectual Property, Technology Transfer and Commercialization
E JAPAN PATENT OFFICE REGIONAL SEMINAR WIPO/REG/IP/SIN/14/INF/2 ORIGINAL: ENGLISH DATE: JULY 21, 2014 Intellectual Property, Technology Transfer and Commercialization organized by the World Intellectual
More informationTecan Group. Corporate Update CONFERENCE CALL JANUARY 15, 2019
Tecan Group Corporate Update CONFERENCE CALL JANUARY 15, 2019 Speakers Dr Lukas Braunschweiler Chairman Dr David Martyr CEO Dr Achim von Leoprechting EVP 2 CEO Succession Tecan just finished another very
More informationOverview of speakers 12th Stakeholders Day. 4-5 april 2017 helsinki, finland
Overview of speakers 12th Stakeholders Day 4-5 april 2017 helsinki, finland Plenary session 1 Opening Geert Dancet became the first elected Executive Director of the European Chemicals Agency (ECHA) in
More informationNVESTOR. 1,400+ Attendees. 2,700+ Partnering Meetings. 768 Companies. 700 Registered Investors. 158 Company Presentations
February 11-12, 2019 New York Marriott Marquis Now in its 21 st year, the BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and
More informationRichard J. Donoghue Senior Vice President for Strategy, Planning and Business Development
Richard J. Donoghue Senior Vice President for Strategy, Planning and Business Development Richard (Rick) J. Donoghue, senior vice president for strategy, planning and business development at NYU Langone
More informationDISCOVERY LECTURE SERIES
DISCOVERY LECTURE SERIES 2015 The Discovery Lecture Series is designed to introduce scientific and mathematical research to our students. Guest lectures have agreed to share their knowledge and expertise
More informationVetter. The experts in complex development, aseptic manufacturing and packaging. Facts figures data 2018
Vetter The experts in complex development, aseptic manufacturing and packaging Facts figures data 2018 This is Vetter Founded *50 Sales 2017 Our portfolio Vetter is an international pharmaceutical service
More informationAccreditation & Designation of NB
Accreditation & Designation of NB Bert Roossien Medical Devices Notified Body BSI Netherlands 07 June 2018 Copyright 2018 BSI. All rights reserved MDF1200 (EU) No 920/2013 In particular, they shall not
More informationCollege of Engineering
College of Engineering Experience American Higher Education in the Gulf American University of Sharjah, founded in 1997, is a not-for-profit, independent, coeducational institution of higher education
More informationUndergraduate and Integrated Masters Programmes
I 1 Undergraduate and Integrated Masters Programmes General note: All programme specifications are subject to change as may from time to time be necessary, and options or alternatives contained in any
More informationDr Rupert Bellinghausen
Dr Rupert Bellinghausen Present Position: Partner, Head of Litigation & Arbitration Germany Office: Frankfurt Nationality: German Date of Birth: 30 January 1966 Profession: Rechtsanwalt Languages: German,
More informationWorkshop on. Evolving the Regulatory Review Process What are the features which enable a transparent, timely, predictable and good quality review?
Workshop on Evolving the Regulatory Review Process What are the features which enable a transparent, timely, predictable and good quality review? 6 7 December 2011 PROGRAMME Intercontinental Hotel, Kuala
More informationInvitation to the Extraordinary General Meeting of UBS AG
Invitation to the Extraordinary General Meeting of UBS AG Thursday, 2 October 2008, 10:30 a.m. (Doors open at 9:30 a.m.) St. Jakobshalle Brüglingerstrasse 21, Basel Status Report of the Board of Directors
More informationLehrkräfte in der CRRA- Ausbildung
Lehrkräfte in der CRRA- Ausbildung Dr. Ferdinand Hund The Program Director of the certificate program in Clinical Research and Regulatory Affairs at the Health Department of the DUW Institut für Weiterbildung
More informationNIHR ROADSHOW FOR MEDTECH SMES
MARTIN HUNT, DIRECTOR FOR INVENTION FOR INNOVATION (i4i) PROGRAMME, NATIONAL INSTITUTE FOR HEALTH RESEARCH Martin is Programme Director for i4i, a translational funding programme. i4i aims to support and
More informationEDQM COUNCIL OF EUROPE CONFERENCE CERTIFICATION PROCEDURE : 20 YEARS OF EXPERIENCE March EDQM, Strasbourg, France ABSTRACTS
EDQM COUNCIL OF EUROPE CONFERENCE CERTIFICATION PROCEDURE 1992-2012: 20 YEARS OF EXPERIENCE 22-23 March 2012 EDQM, Strasbourg, France ABSTRACTS PLENARY SESSION, 22 March 2012 ABSTRACT 1.3 The Evolution
More informationPrevious Attendees List:
Previous Attendees List: Company 3M Abbott Abbott Point of Care Abbott Vascular ACIST Medical ACIST Medical Systems Adamas Pharmaceuticals Aileron Holdings Allergan Allergan Allergan Ansell Healthcare
More informationMSLOC - Global Thought Leader Roundtable ERIC N. FRIDMAN
ERIC N. FRIDMAN Assistant Dean and Director of Marketing for Executive Education, Northwestern University s Kellogg School of Management Eric Fridman is Assistant Dean and Director of Marketing for Executive
More informationBOARD OF DIRECTORS. PETER WEHRLY Chair
BOARD OF DIRECTORS PETER WEHRLY Chair Peter Wehrly is the former group president of developed markets at Covidien, the manufacturer of medical devices with sales of over $10.7 billion (2014). Peter held
More informationA Day in the Life of a Science
A Day in the Life of a Science Policy Professional Jennifer A. Hobin, PhD Director of Science Policy Federation of American Societies for Experimental Biology What is Science Policy? Science for Policy
More informationCurrent Status and Challenges of Bilateral/Multilateral Meetings
Current Status and Challenges of Bilateral/Multilateral Meetings Junko Sato, PhD International Liaison Officer PMDA 26th Annual EuroMeeting 25-27 March 2014 ACV, Vienna Austria Disclaimer The views and
More informationOCRA Orange County Regulatory Affairs Discussion Group. Christine Posin, President June 9, 2008
OCRA Orange County Regulatory Affairs Discussion Group Christine Posin, President June 9, 2008 What is OCRA? Orange County Regulatory Affairs Discussion Group Volunteer organization 501{c}(6) Non-profit
More informationMEDICAL DEVICE INNOVATION IN GERMANY
MEDICAL DEVICE INNOVATION IN GERMANY Richard Schill TOKYO, 1 December 2016 Personal Introduction Richard Schill German married, 3 children Education University of Würzburg, Germany: Diploma in Business
More informationFrançois Grémy, a humanist and information sciences pioneer
François Grémy, a humanist and information sciences pioneer Patrice Degoulet 1, Marius Fieschi 2, Marcel Goldberg 3, Roger Salamon 4 1 René Descartes University, Paris, France, 2 Aix Marseille University,
More informationAussendung der Stellungnahme des BMGF zum Thesis Paper über das 9. EU-RTD- Rahmenprogramm
Frau Mag. Andrea Höglinger Andrea.Hoeglinger@ffg.at Organisationseinheit: BMGF - I/FXEL (Fachexpertin DI Dr. Eva Lang) Sachbearbeiter/in: DI Dr. Eva-Claudia Lang E-Mail: eva-claudia.lang@bmgf.gv.at Telefon:
More informationUndergraduate Programmes
I 1 General note: All programme specifications are subject to change as may from time to time be necessary, and options or alternatives contained in any programme specification will not necessarily all
More informationMedTech Alliance Program Spring Meeting
Oregon Health & Science University Presents: MedTech Alliance Program Spring Meeting OHSU will be hosting its second MedTech Alliance program meeting on Wednesday, May 6 from 5:00PM to 7:30PM. Community
More informationIndustry Advisory Board Harper Cancer Research Institute
Industry Advisory Board Harper Cancer Research Institute Gaylene Anderson, M.B.A. US Director Contracts and Alliance Management Boehringer Ingelheim Pharmaceuticals Gaylene is the US Director of Contracts
More informationTOPRA Annual Medical Devices Symposium 2017
19 TOPRA Annual Medical Devices Symposium 2017 Regulatory challenges today and tomorrow SESSION 1: Optimising the implementation of the new MDR Reported by Tiffany Powell, Senior Regulatory Affairs Manager
More informationFirst Course Lobster Bisque Soup with Roasted Fennel. Bread Service Caramelized Onion Walnut Roll with Whipped Maple Brie
Innovation Wing National Museum of American History Smithsonian Institution April 14, 2016 DINNER MENU First Course Lobster Bisque Soup with Roasted Fennel Bread Service Caramelized Onion Walnut Roll with
More informationTRANSLATIONAL SCIENCE
TRANSLATIONAL SCIENCE A Discussion of Best Practices and Unique Models Wednesday January 31, 2018 at The NYSCF Research Institute HRA TRI-STATE REGIONAL MEETING 31 Wednesday January, 2018 AGENDA 8:30 AM
More informationScripps Florida. Accelerating Discoveries, Saving Lives. Presentation to the Urban Land Institute November 4, 2011
Scripps Florida Accelerating Discoveries, Saving Lives Presentation to the Urban Land Institute November 4, 2011 Alex Bruner Associate Vice President, Philanthropy 1921- Founding of the Scripps Metabolic
More informationEPD ENGINEERING PRODUCT DEVELOPMENT
EPD PRODUCT DEVELOPMENT PILLAR OVERVIEW The following chart illustrates the EPD curriculum structure. It depicts the typical sequence of subjects. Each major row indicates a calendar year with columns
More informationMastering Environmental Monitoring
pda.org/eu/em2019 2019 PDA EUROPE TRAINING Mastering Environmental Monitoring 15-16 OCTOBER 2019 WATTWIL, SWITZERLAND CONNECTING PEOPLE SCIENCE AND REGULATION Training & Education Program europe.pda.org
More informationPeter Smith. He has two daughters, Natalie and Christina, both of whom played for the McGill Martlets.
MANAGEMENT FORUM CONFERENCE LEADERS TEAMS AND LIFE NOVEMBER 17 2010 Peter Smith Peter Smith, a native of Lachine, Que., was appointed head coach at McGill University in 1999 and took a one-year sabbatical
More informationKoen Dejonckheere. Professional experience. Board Memberships. Education
Koen Dejonckheere Professional experience KBC SECURITIES GROUP 2002-2008 Managing Director, responsible for Corporate Finance Previously, Koen Dejonckheere was active in Corporate Finance and Private Equity
More informationOslo IMIA Board and General Assembly Meetings August 27-28, GA Agenda Item: 15 Board Agenda Item: 15. August 2011
Oslo IMIA Board and General Assembly Meetings August 27-28, 2011 GA Agenda Item: 15 Board Agenda Item: 15 Nominating Committee Report August 2011 Elizabeth Borycki (Canada) Reinhold Haux (Germany), Chair
More informationAbraxis: Emergent Life Science & Pharmaceutical Company
Abraxis: Emergent Life Science & Pharmaceutical Company Abraxis BioScience, Inc. Michael J. Brunelle, VP Acquisition & Development UGL Equis Mark Berman, Managing Director Brad Gross, Senior Vice President
More informationLife Sciences Regulatory
Life Sciences Regulatory Pharmaceuticals 2018 2 Life Sciences Regulatory Pharmaceuticals 2018 Top ranked in Chambers and Legal 500 for Life Sciences, pharmaceuticals and biotechnology. Allen & Overy LLP
More informationBayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division
Bayer Inc. Science for a Better Life Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division Please review your career path to date, leading to your
More informationForum. CEO Clubs Workshop & Forum Monday, 15 th October 2012 Hilton Athens. Keynote Speaker Dr. Srini Pillay. Rewiring Your Innovation DNA
th October 2012 Hilton Athens Walking Keynote Speaker Dr. Srini Pillay Harvard faculty, world leader in stress, anxiety and resilience. Award-winning author on linking brain based strategies to business.
More informationAdvisory Board. Advisory Board. Advisory Board (1) GMP Manual (Up05) Maas & Peither AG GMP Publishing
(1) Virginia G. Beakes-Read Genentech, USA Ginny works for Genentech, Inc., as the Director, Regulatory Policy Liaison, for the Strategic Operations Office in Washington, D.C. She works on a variety of
More informationgellerbiopharm A healthcare investment banking division of Financial West Group, member FINRA/SIPC. Office (212) Web gellerbp.
gellerbiopharm A healthcare investment banking division of Financial West Group, member FINRA/SIPC. Office (212) 315-0600 Web gellerbp.com Summary Personal Diverse, world-class team of top biotech bankers,
More informationCURRICULUM VITAE PATRICIA E. (STEWART) GUSSIN
CURRICULUM VITAE PATRICIA E. (STEWART) GUSSIN ADDRESS: Longboat Key, Florida Amagansett, NY 11930 E-Mail: gussins@oceanviewpub.com Facebook: www.facebook.com/patricia.gussin PLACE OF BIRTH: Grand Rapids,
More informationUndergraduate Programmes
I 1 General note: All programme specifications are subject to change as may from time to time be necessary, and options or alternatives contained in any programme specification will not necessarily all
More informationInclusion Women at the Forefront of STEM
Innovation and Inclusion Women at the Forefront of STEM Hosted by the Association for Women in Science SPONSORSHIP Innovation and Inclusion: Women at the Forefront of STEM The Association for Women in
More informationAppendix: Author Biographies
Appendix: Author Biographies Steven R. Alexander, M.D., is Medical Director, Spectrum Operations, Training and Compliance, Stanford Center for Clinical & Translational Education & Research. He is Professor
More informationCORNELL GLOBAL SOLUTIONS CASE STUDY PRESENTATION
2010 United Nations Public Service Day - Awards and Forum 21-23 June 2010, Barcelona, Spain EXPERT GROUP MEETING Developing Institutional Capacities of Public Administration for the Achievement of MDGs
More informationLSIF Convenor s Summary Report to CTI
2016/SOM1/CTI/054 Agenda Item: 11 LSIF Convenor s Summary Report to CTI Purpose: Consideration Submitted by: LSIF PG Chair First Committee on Trade and Investment Meeting Lima, Peru 28-29 February 2016
More informationFood Chemistry & Nutrition
3rd International Conference on Food Chemistry & Nutrition May 16-18, 2018 Montreal, Canada https://foodchemistry.conferenceseries.com/ Invitation Dear Attendees, We are glad to announce the 3rd International
More informationCross-Border R&D in China Understanding the Regulatory Challenges
1 2 Cross-Border R&D in China Understanding the Regulatory Challenges 1 Panelists Moderator: Paul A. Stewart, Silicon Valley Office Managing Partner, Foley & Lardner LLP Speakers: David Rosen, Partner,
More information2015 Primerus Legal Risk Management Seminar: A Comparative Analysis by World Region. Intellectual Property Protecting Your Assets in a Volatile Market
2015 Primerus Legal Risk Management Seminar: A Comparative Analysis by World Region Intellectual Property Protecting Your Assets in a Volatile Market Thursday, October 1, 2015 (2:45 p.m. 3:15 p.m.) Presented
More informationPharmaceutical Products and Services
Pharmaceutical Products and Services Johnson Matthey (JM) combines specialist expertise and a 200-year heritage, to deliver a collaborative service offering focused on strengthening your products to ensure
More informationAMCo current. Medpace new in Sebia realised. Spire Healthcare partially realised. Healthcare. Sector insights. Our Healthcare portfolio in 2014
Sector insights The healthcare market is highly complex with global products delivered through local services and channels. The healthcare value chain is intricate, diverse and interdependent. It is a
More informationDay 1. Opening Session
Day 1. Opening Session Opening Remarks: Mr. Jong-Soo Yoon, Head of Office, UNOSD Mr. Jong-Soo Yoon is the former Vice-Minister of Environment and an environmental expert in sustainable development. With
More informationHealth & Social Care Industrial Innovation
Health & Social Care Industrial Innovation Mr Andrew Fowlie Scottish Government Health Innovations Team SHINE North Sea Region Program 2014 2020 Scotland s Medical Technologies Landscape Imaging Non Imaging
More information